Abstract
Diagnosis and surgical treatment of neuroendocrine insulin-producing tumor of the pancreas using genetic testing
Highlights
Neuroendocrine tumors (NET) occur with a frequency of up to 4% among all pancreatic tumors
Patient G., born in 1983, applied to the Shalimov National Institute of Surgery and Transplantology for medical help with severe symptoms of hyperinsulinism and hypoglycemia, which is characteristic of NET
Insulinoma was diagnosed in accordance with current clinical guidelines and histopathologically confirmed
Summary
Neuroendocrine tumors (NET) occur with a frequency of up to 4% among all pancreatic tumors (pancreas). Diagnosis and surgical treatment of neuroendocrine insulin–producing tumor of the pancreas using genetic testing Shalimov National Institute of Surgery and Transplantology, Kyiv NET pancreas are divided into functioning (hormonally active) and non-functioning (hormonally inadequate).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
